References
- Boring CC, Squires TS, Tong T. Cancer statistics: 1991. CA 1991;41(1):19
- Newcomb PA, Carbone PP. The health consequences of smoking: cancer. Med Clin North Am 1992;76(2):305–31
- Fiore MC, Novotny TE, Pierce JP, et al. Trends in cigarette smoking in the United States: the changing influence of gender and race. JAMA 1989;261(l):49–55
- Goldstein AO. Youth and tobacco: addiction and death. N C Med J 1992;53(8):411–3
- Office of the Surgeon General. The Health consequences of smoking: nicotine addiction. A report of the Surgeon General, 1988. Rockville, Md: US Dept of Health and Human Services, 1988; DHHS publication No.(CDC)88-8406
- Benowitz NL. Drug therapy: pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319(20):1318–30
- Rose JE, Levin ED, Behm FM, et al. Transdermal nicotine acilitates smoking cessation. Clin Pharmacol Ther 1990;47(3):323–30
- Nicotine patches. Med Lett Drugs Ther 1992;34(868):37–8
- Tennesen P, Nørregaard J, Simonsen K et al. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991;325(5):311–5
- Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988;259(19):2863–6
- Robinson MD, Smith WA, Cederstrom EA, et al. Buspirone effect on tobacco withdrawal symptoms: a pilot study. J Am Board Fam Pract 1991;4(2):89–94
- West R, Hajek P, McNeill A. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology (Berl) 1991;104(1): 91–6
- Robinson MD, Pettice YL, Smith WA, et al. Buspirone effect on tobacco withdrawal symptoms: a randomized placebo-controlled trial. J Am Board Fam Pract 1992;5(l):1–9